Gordon A. Ulsh

This profile gathers the share dealings of Gordon A. Ulsh across 3 companies, led by Exide Technologies, OM Group Inc and Cellu Tissue Holdings, Inc. Over a trading history stretching from 14 February 2006 to 22 January 2013, the count stands at 170 filings.

Both buying and selling appear: 33 purchases worth €176k, against 93 sales worth €217k. Taken together, the sales exceed the purchases by €41k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 33 share grants.

Half of the purchases are above €1,833 and half below.

Most recently, on 24 January 2013, the filings show a share grant worth €14k in OM Group Inc. The most recent open-market purchase was published on 27 November 2007, 6,906 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.